Last updated on 25 Jul 2022
Owner Info
Amylyx Pharmaceuticals, Inc.
43 Thorndike Street
Cambridge, Massachusetts, 02141 UNITED STATES OF AMERICA,
Serial Number
2264257 filed on 20 Apr 2022
Correspondent
Davies Collison Cave Pty Ltd
Level 4,
7 Macquarie Place,
Sydney, NSW, 2000 AUSTRALIA
2264257
20 Apr 2022
20 Apr 2032
WORD
17 Dec 2021
US
Status Date | Action Taken |
---|---|
25th Jul 2022 | IP Right Registered correspondence sent |
25th Jul 2022 | IP Right Registration Published |
25th Jul 2022 | Status change to Registered/Protected |
18th May 2022 | Application Accepted correspondence sent |
18th May 2022 | IP Right has been Examined |
18th May 2022 | IP Right Acceptance Published |
27th Apr 2022 | Early Acceptance Notice correspondence sent |
27th Apr 2022 | Status change to Accepted |
26th Apr 2022 | Awaiting examination |
26th Apr 2022 | Examination expedited |